180 related articles for article (PubMed ID: 33742520)
1. The ViKTORIES trial: A randomized, double-blind, placebo-controlled trial of vitamin K supplementation to improve vascular health in kidney transplant recipients.
Lees JS; Rankin AJ; Gillis KA; Zhu LY; Mangion K; Rutherford E; Roditi GH; Witham MD; Chantler D; Panarelli M; Jardine AG; Mark PB
Am J Transplant; 2021 Oct; 21(10):3356-3368. PubMed ID: 33742520
[TBL] [Abstract][Full Text] [Related]
2. Vitamin K for kidney transplant organ recipients: investigating vessel stiffness (ViKTORIES): study rationale and protocol of a randomised controlled trial.
Lees JS; Mangion K; Rutherford E; Witham MD; Woodward R; Roditi G; Hopkins T; Brooksbank K; Jardine AG; Mark PB
Open Heart; 2020 Jul; 7(2):. PubMed ID: 32675297
[TBL] [Abstract][Full Text] [Related]
3. Effect of vitamin K supplementation on serum calcification propensity and arterial stiffness in vitamin K-deficient kidney transplant recipients: A double-blind, randomized, placebo-controlled clinical trial.
Eelderink C; Kremer D; Riphagen IJ; Knobbe TJ; Schurgers LJ; Pasch A; Mulder DJ; Corpeleijn E; Navis G; Bakker SJL; de Borst MH; Te Velde-Keyzer CA
Am J Transplant; 2023 Apr; 23(4):520-530. PubMed ID: 36695702
[TBL] [Abstract][Full Text] [Related]
4. Vitamin K2 supplementation and arterial stiffness among renal transplant recipients-a single-arm, single-center clinical trial.
Mansour AG; Hariri E; Daaboul Y; Korjian S; El Alam A; Protogerou AD; Kilany H; Karam A; Stephan A; Bahous SA
J Am Soc Hypertens; 2017 Sep; 11(9):589-597. PubMed ID: 28756183
[TBL] [Abstract][Full Text] [Related]
5. Vitamin K Supplementation to Improve Vascular Stiffness in CKD: The K4Kidneys Randomized Controlled Trial.
Witham MD; Lees JS; White M; Band M; Bell S; Chantler DJ; Ford I; Fulton RL; Kennedy G; Littleford RC; McCrea IV; McGlynn D; Panarelli M; Ralston MR; Rutherford E; Severn A; Thomson N; Traynor JP; Struthers AD; Wetherall K; Mark PB
J Am Soc Nephrol; 2020 Oct; 31(10):2434-2445. PubMed ID: 32817311
[TBL] [Abstract][Full Text] [Related]
6. The effect of six-month oral vitamin K supplementation on calcification propensity time in individuals with type 2 diabetes mellitus: A post hoc analysis of a randomized, double-blind, placebo-controlled trial.
Meer R; Romero Prats ML; Vervloet MG; van der Schouw YT; de Jong PA; Beulens JWJ
Atherosclerosis; 2024 Jul; 394():117307. PubMed ID: 37852868
[TBL] [Abstract][Full Text] [Related]
7. Inhibit progression of coronary artery calcification with vitamin K in hemodialysis patients (the iPACK-HD study): a randomized, placebo-controlled multi-center, pilot trial.
Holden RM; Booth SL; Zimmerman D; Moist L; Norman PA; Day AG; Menard A; Fu X; Shea MK; Babiolakis CS; Nolan R; Turner ME; Ward E; Kaufmann M; Adams MA; Heyland DK
Nephrol Dial Transplant; 2023 Feb; 38(3):746-756. PubMed ID: 35641194
[TBL] [Abstract][Full Text] [Related]
8. Study protocol of the InterVitaminK trial: a Danish population-based randomised double-blinded placebo-controlled trial of the effects of vitamin K (menaquinone-7) supplementation on cardiovascular, metabolic and bone health.
Kampmann FB; Thysen SM; Nielsen CFB; Kofoed KF; Køber L; Pham MHC; Vaag A; Jørgensen NR; Petersen J; Jacobsen RK; Kårhus LL; Diederichsen A; Frimodt-Møller M; Linneberg A
BMJ Open; 2023 May; 13(5):e071885. PubMed ID: 37208133
[TBL] [Abstract][Full Text] [Related]
9. The effect of vitamin K1 on arterial calcification activity in subjects with diabetes mellitus: a post hoc analysis of a double-blind, randomized, placebo-controlled trial.
Bellinge JW; Francis RJ; Lee SC; Bondonno NP; Sim M; Lewis JR; Watts GF; Schultz CJ
Am J Clin Nutr; 2022 Jan; 115(1):45-52. PubMed ID: 34637494
[TBL] [Abstract][Full Text] [Related]
10. Menaquinone-7 Supplementation to Reduce Vascular Calcification in Patients with Coronary Artery Disease: Rationale and Study Protocol (VitaK-CAC Trial).
Vossen LM; Schurgers LJ; van Varik BJ; Kietselaer BL; Vermeer C; Meeder JG; Rahel BM; van Cauteren YJ; Hoffland GA; Rennenberg RJ; Reesink KD; de Leeuw PW; Kroon AA
Nutrients; 2015 Oct; 7(11):8905-15. PubMed ID: 26516910
[TBL] [Abstract][Full Text] [Related]
11. A randomized control trial to assess the impact of vitamin D supplementation compared to placebo on vascular stiffness in chronic kidney disease patients.
Levin A; Perry T; De Zoysa P; Sigrist MK; Humphries K; Tang M; Djurdjev O
BMC Cardiovasc Disord; 2014 Nov; 14():156. PubMed ID: 25381032
[TBL] [Abstract][Full Text] [Related]
12. The effect of menaquinone-7 supplementation on vascular calcification in patients with diabetes: a randomized, double-blind, placebo-controlled trial.
Zwakenberg SR; de Jong PA; Bartstra JW; van Asperen R; Westerink J; de Valk H; Slart RHJA; Luurtsema G; Wolterink JM; de Borst GJ; van Herwaarden JA; van de Ree MA; Schurgers LJ; van der Schouw YT; Beulens JWJ
Am J Clin Nutr; 2019 Oct; 110(4):883-890. PubMed ID: 31387121
[TBL] [Abstract][Full Text] [Related]
13. Vitamin K Supplementation for the Prevention of Cardiovascular Disease: Where Is the Evidence? A Systematic Review of Controlled Trials.
Vlasschaert C; Goss CJ; Pilkey NG; McKeown S; Holden RM
Nutrients; 2020 Sep; 12(10):. PubMed ID: 32977548
[TBL] [Abstract][Full Text] [Related]
14. Treatment to reduce vascular calcification in hemodialysis patients using vitamin K (Trevasc-HDK): A study protocol for a randomized controlled trial.
Haroon SW; Tai BC; Ling LH; Teo L; Davenport A; Schurgers L; Teo BW; Khatri P; Ong CC; Low S; Yeo XE; Tan JN; Subramanian S; Chua HR; Tan SY; Wong WK; Lau TW
Medicine (Baltimore); 2020 Sep; 99(36):e21906. PubMed ID: 32899022
[TBL] [Abstract][Full Text] [Related]
15. Reversal Of Arterial Disease by modulating Magnesium and Phosphate (ROADMAP-study): rationale and design of a randomized controlled trial assessing the effects of magnesium citrate supplementation and phosphate-binding therapy on arterial stiffness in moderate chronic kidney disease.
Vermeulen EA; Eelderink C; Hoekstra T; van Ballegooijen AJ; Raijmakers P; Beulens JW; de Borst MH; Vervloet MG
Trials; 2022 Sep; 23(1):769. PubMed ID: 36096824
[TBL] [Abstract][Full Text] [Related]
16. Slowing Progression of Cardiovascular Calcification With SNF472 in Patients on Hemodialysis: Results of a Randomized Phase 2b Study.
Raggi P; Bellasi A; Bushinsky D; Bover J; Rodriguez M; Ketteler M; Sinha S; Salcedo C; Gillotti K; Padgett C; Garg R; Gold A; Perelló J; Chertow GM
Circulation; 2020 Mar; 141(9):728-739. PubMed ID: 31707860
[TBL] [Abstract][Full Text] [Related]
17. Inhibiting the progression of arterial calcification with vitamin K in HemoDialysis patients (iPACK-HD) trial: rationale and study design for a randomized trial of vitamin K in patients with end stage kidney disease.
Holden RM; Booth SL; Day AG; Clase CM; Zimmerman D; Moist L; Shea MK; McCabe KM; Jamal SA; Tobe S; Weinstein J; Madhumathi R; Adams MA; Heyland DK
Can J Kidney Health Dis; 2015; 2():17. PubMed ID: 26075081
[TBL] [Abstract][Full Text] [Related]
18. Effect of Menaquinone-7 Supplementation on Arterial Stiffness in Chronic Hemodialysis Patients: A Multicenter Randomized Controlled Trial.
Naiyarakseree N; Phannajit J; Naiyarakseree W; Mahatanan N; Asavapujanamanee P; Lekhyananda S; Vanichakarn S; Avihingsanon Y; Praditpornsilpa K; Eiam-Ong S; Susantitaphong P
Nutrients; 2023 May; 15(11):. PubMed ID: 37299386
[TBL] [Abstract][Full Text] [Related]
19. The effect of Vitamin-K
Bellinge JW; Francis RJ; Lee SC; Vickery A; Macdonald W; Gan SK; Chew GT; Phillips M; Lewis JR; Watts GF; Schultz CJ
J Nucl Cardiol; 2022 Aug; 29(4):1855-1866. PubMed ID: 33825140
[TBL] [Abstract][Full Text] [Related]
20. Effect of vitamin K2 supplementation on functional vitamin K deficiency in hemodialysis patients: a randomized trial.
Westenfeld R; Krueger T; Schlieper G; Cranenburg EC; Magdeleyns EJ; Heidenreich S; Holzmann S; Vermeer C; Jahnen-Dechent W; Ketteler M; Floege J; Schurgers LJ
Am J Kidney Dis; 2012 Feb; 59(2):186-95. PubMed ID: 22169620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
